About Serine/threonine-protein phosphatase 5
Serine/threonine-protein phosphatase 5 (PPP5C) is a protein
from Homo sapiens identified by UniProt accession
P53041, 499 residues long.
MolForge cross-references it against 0 known binders and
98 disease associations.
Target properties
| Protein name | Serine/threonine-protein phosphatase 5 |
| UniProt accession | P53041 |
| Gene | PPP5C |
| Organism | Homo sapiens |
| Length | 499 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (98)
Diseases linked to this target (Open Targets).
- hemoglobin measurement · score 0.35
- lymphocyte count · score 0.33
- eosinophil count · score 0.32
- Crohn's disease · score 0.31
- triglyceride measurement · score 0.31
- breast adenocarcinoma · score 0.29
- eosinophil percentage of leukocytes · score 0.29
- erythrocyte count · score 0.27
- monocyte count · score 0.27
- neurodegenerative disease · score 0.26
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-P53041-F1 | alphafold | PREDICTED | 92.77 | — |
Amino-acid sequence (499 residues)
MAMAEGERTE CAEPPRDEPP ADGALKRAEE LKTQANDYFK AKDYENAIKF YSQAIELNPS NAIYYGNRSL AYLRTECYGY ALGDATRAIE LDKKYIKGYY RRAASNMALG KFRAALRDYE TVVKVKPHDK DAKMKYQECN KIVKQKAFER AIAGDEHKRS VVDSLDIESM TIEDEYSGPK LEDGKVTISF MKELMQWYKD QKKLHRKCAY QILVQVKEVL SKLSTLVETT LKETEKITVC GDTHGQFYDL LNIFELNGLP SETNPYIFNG DFVDRGSFSV EVILTLFGFK LLYPDHFHLL RGNHETDNMN QIYGFEGEVK AKYTAQMYEL FSEVFEWLPL AQCINGKVLI MHGGLFSEDG VTLDDIRKIE RNRQPPDSGP MCDLLWSDPQ PQNGRSISKR GVSCQFGPDV TKAFLEENNL DYIIRSHEVK AEGYEVAHGG RCVTVFSAPN YCDQMGNKAS YIHLQGSDLR PQFHQFTAVP HPNVKPMAYA NTLLQLGMM
Explore Serine/threonine-protein phosphatase 5 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets